aaiPharma coverage suspended by Jefferies

aaiPharma Inc. coverage was suspended by Jefferies & Co. analyst David Windley on uncertainty about the outcome of its bankruptcy, specifically the lack of clarity as to whether it will continue to be a publicly traded company post-reorganization. aaiPharma shares Friday dropped $0.11, or 13.58%, to $0.70 on volume of 1,230,088 shares versus the three-month running average of 248,203.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.